Roche Diagnostics and Diabetes UK
Type of organisation: Medical Technology & Diagnostics
At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give us all more time with the people we love.
We are proud to be the UK’s leading provider of in vitro diagnostic tests1. We also work in partnership with the NHS and other healthcare providers to try and ensure every patient journey begins with an early and accurate diagnosis, and to play our part in the delivery of efficient and effective healthcare for everyone.
In the UK, in 2020, more than 820 million Roche diagnostic tests were used by clinicians to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-19, hepatitis, human papillomavirus (HPV) and many others2.
Through Roche’s direct business activities and employee spending, we contribute £1.26 billion to the UK economy and provide 21,260 jobs3. We also invested more than £400 million in UK Research and Development (R&D) in 20214.
For more information, please visit – website: www.roche.co.uk – Twitter: @RocheDiaUK – LinkedIn: @Roche Diagnostics UK and Ireland
- Data on file
- Business Intelligence Team at Roche Diagnostics
- PwC analysis of data from Finance teams at Roche Products, Roche Diagnostics and Roche Diabetes Care
- Office for Life Sciences Competitiveness Indicators
Roche Diagnostics and Diabetes UK news articles
20 October 2022
Roche launches next generation of rapid antigen tests
1 April 2022
Harnessing digitalisation in point of care to deliver greater value
23 July 2021
Report calls for breakthrough diagnostics to be funded like new medicines